Recombinant Human EGF Market Growth Accelerated by Expanding Medical Applications

 


Recombinant human epidermal growth factor (EGF) has applications in supporting cell differentiation, regeneration and wound healing. EGF promotes proliferation of keratinocytes and epithelial cells to accelerate wound healing. Given EGF's role in tissue repair and regeneration, it finds use in treatment of chronic ulcers, burn wounds and maxillofacial reconstructions. EGF is also used in formulations for skin care and anti-aging products due its rejuvenating properties.

The global Recombinant Human (EGF) Market is estimated to be valued at US$ 10,251.1 Mn in 2023 and is expected to exhibit a CAGR of 9.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The expanding applications of EGF in various medical therapies is one of the key trends driving the growth of this market. EGF has demonstrated efficacy in expediting wound healing and shown promise in treatment of various disorders involving impaired wound healing such as diabetic foot ulcers. EGF supplements are being widely researched for therapeutic potential in chronic diseases such as inflammatory bowel disease (IBD), neurodegenerative diseases and cancers. Furthermore, ongoing development of gene therapy and regenerative medicine approaches utilizing EGF are anticipated to present new opportunities for market players over the forecast period.

Segment Analysis:    
The global recombinant human (EGF) market is dominated by the therapeutics segment which accounted for over 60% share of the market in 2024. Recombinant EGF is primarily used for wound healing and in therapeutics for conditions like corneal injuries, gastric ulcers, and dermal wounds. It promotes proliferation, chemotaxis, and differentiation of various cell types. As the aging population is rising worldwide and cases of chronic wounds are increasing, the demand for recombinant EGF in therapeutics is expected to grow at a higher rate during the forecast period.

Key Takeaways:
The global recombinant human (EGF) market is expected to witness high growth.

Regional analysis: North America dominated the global recombinant human (EGF) market in 2024 and accounted for over 40% share. This can be attributed to factors such as rising prevalence of chronic wounds, increasing research activities, and growing biopharmaceutical industry in the region. Asia Pacific is expected to witness the fastest growth during the forecast period owing to rapidly growing biotechnology sector, rising medical tourism, and increasing investment by key market players in the region.

Key players operating in the recombinant human (EGF) market are Thermo Fisher Scientific, FUJIFILM Irvine Scientific, Inc., ScienCell Research Laboratories, R&D Systems, Abcam PLC, Cell Sciences, Inc., Eurofins DiscoverX, PeproTech, Inc., RayBiotech, Inc., Prospec-Tany TechnoGene Ltd., Miltenyi Biotec, Tonbo Biosciences, BioLegend, Inc., EnQuire BioReagents, STEMCELL Technologies Inc., Cell Guidance Systems Ltd., Creative BioMart, Sino Biological Inc., and BioVision, Inc.

Comments

Post a Comment

Popular posts from this blog

Neuroendocrine Cancer is the fastest growing segment fueling the growth of Pituitary Cancer Market

Image
The pituitary cancer market comprises of medical treatment options for patients diagnosed with pituitary cancer. Pituitary cancers are rare tumors that start in the pituitary gland which is a pea-sized gland located at the base of the brain.  The global Pituitary Cancer Market is estimated to be valued at US$ 380.7 Mn in 2023 and is expected to exhibit a CAGR of 9.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.    Market key trends: One of the key trends fueling the growth of the pituitary cancer market is rising preference of targeted drug therapy over conventional chemotherapy. Targeted drug therapies mainly include somatostatin analogs and dopamine agonists which directly act on cancer cells and have less side effects compared to chemotherapy. These targeted drugs are effective in controlling symptoms and slowing tumor growth in patients with hormone secreting pituitary adenomas and carcinomas. The targe...
Read more

Enhancing Patient Care and Comfort: The Evolution of Hospital Beds

Image
  Hospital beds play a crucial role in patient care, providing comfort, safety, and functionality for individuals requiring medical attention. Over the years, advancements in technology and design have revolutionized hospital beds, leading to improved patient outcomes and caregiver efficiency. From basic adjustable beds to sophisticated models equipped with cutting-edge features, the evolution of hospital beds has transformed the healthcare landscape. Evolution of Hospital Beds: Historically, hospital beds were simple in design, primarily consisting of a metal frame with adjustable height and manual controls. However, as medical practices advanced and patient needs became more complex, the demand for more versatile and ergonomic hospital beds grew. In recent decades, significant strides have been made in the development of hospital bed technology. Modern hospital beds are designed with a focus on patient comfort, safety, and mobility. Features such as electronic controls, motorize...
Read more

Dry Eye Disease Market is Estimated to Witness High Growth Owing to Rising Awareness About Disease Management

Image
  Dry eye disease, also known as keratoconjunctivitis sicca, is a multifactorial disease of the ocular surface characterized by lack of sufficient moisture and tear film instability. Common symptoms of dry eye include stingy or burning sensation in eyes and blurred vision.   Market Dynamics : The Dry Eye Disease Market is witnessing high growth owing to rising awareness about disease management and increasing number of people experiencing symptoms of dry eyes. According to the report, increasing usage of electronic devices and prolonged screen time is a major driver fueling the demand for dry eye treatments. Additionally, growing geriatric population worldwide who are more prone to dry eyes is also contributing to the market growth. Availability of various treatment options along with new product launches is further expected to boost the market during forecast period.   Increasing Prevalence of Dry Eye Disease is Driving Market Growth   One of the major market drive...
Read more